SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-20-000112
Filing Date
2020-07-27
Accepted
2020-07-27 06:50:14
Documents
18
Period of Report
2020-07-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebs-2020x07x27az8xk.htm   iXBRL 8-K 50335
2 EXHIBIT 99 a072720astrazenecacovid1.htm EX-99 11195
8 a072720astrazenecacovid1001.jpg GRAPHIC 269326
9 a072720astrazenecacovid1002.jpg GRAPHIC 270780
10 a072720astrazenecacovid1003.jpg GRAPHIC 188040
  Complete submission text file 0001367644-20-000112.txt   1219380

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20200726.xsd EX-101.SCH 4492
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebs-20200726_cal.xml EX-101.CAL 662
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebs-20200726_def.xml EX-101.DEF 1512
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20200726_lab.xml EX-101.LAB 27268
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20200726_pre.xml EX-101.PRE 14152
11 EXTRACTED XBRL INSTANCE DOCUMENT ebs-2020x07x27az8xk_htm.xml XML 4333
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 201048122
SIC: 2834 Pharmaceutical Preparations